Access BNP II— 510(k) K252169

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K252169 for Access BNP II, Substantially Equivalent on 2026-03-24. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code NBC
Advisory panel: Clinical Chemistry
Date received: 2025-07-10
Decision date: 2026-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.